Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mycobacterial infections

C A Peloquin1

  • 1Infectious Disease Pharmacokinetics Laboratory, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.

Pharmacotherapy
|November 1, 1993
PubMed
Summary

Tuberculosis (TB) infection is increasing in the US, with drug-resistant strains spreading. New treatment strategies are being developed for TB and Mycobacterium avium infections, especially in immunocompromised patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pretomanid dosing and pharmacokinetics in patients with TB in a high-resource setting.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial.

The Journal of infectious diseases·2025
Same author

Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB.

IJTLD open·2024
Same author

Therapeutic drug monitoring for isoniazid and rifampicin exposure.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2024
Same author

Effect of HIV infection on plasma exposure to first-line TB drugs and target attainment in children.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Clinical standards for the management of adverse effects during treatment for TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Mycobacterium tuberculosis remains a significant global health threat.
  • Increasing incidence and emergence of multidrug-resistant tuberculosis (MDR-TB) strains in the United States.
  • Mycobacterium avium complex (MAC) infections cause substantial morbidity and mortality in individuals with acquired immunodeficiency syndrome (AIDS).

Purpose of the Study:

  • To review current strategies for managing tuberculosis (TB) epidemics.
  • To discuss challenges and advancements in treating Mycobacterium avium infections in AIDS patients.
  • To highlight the need for improved therapeutic regimens.

Main Methods:

  • Literature review of epidemiological data on TB and MAC infections.
  • Analysis of treatment guidelines and clinical trial outcomes.
  • Synthesis of information on drug resistance, intolerance, and malabsorption issues.

Main Results:

  • Tuberculosis incidence and MDR-TB spread are worsening in the US.
  • Limited therapeutic options exist for Mycobacterium avium infections due to drug resistance, intolerance, and malabsorption.
  • Development of potentially effective treatment regimens is ongoing.

Conclusions:

  • Effective management strategies are crucial to combat the rising TB epidemic.
  • Advancements in therapeutic regimens are needed to improve outcomes for Mycobacterium avium infections in AIDS patients.
  • Continued research is essential for developing better treatments for these challenging infections.

Related Experiment Videos